249 related articles for article (PubMed ID: 19781661)
1. Differential expression of alpha-2,3-sialyltransferases and alpha-1,3/4-fucosyltransferases regulates the levels of sialyl Lewis a and sialyl Lewis x in gastrointestinal carcinoma cells.
Carvalho AS; Harduin-Lepers A; Magalhães A; Machado E; Mendes N; Costa LT; Matthiesen R; Almeida R; Costa J; Reis CA
Int J Biochem Cell Biol; 2010 Jan; 42(1):80-9. PubMed ID: 19781661
[TBL] [Abstract][Full Text] [Related]
2. α2,3-Sialyltransferase ST3Gal IV promotes migration and metastasis in pancreatic adenocarcinoma cells and tends to be highly expressed in pancreatic adenocarcinoma tissues.
Pérez-Garay M; Arteta B; Llop E; Cobler L; Pagès L; Ortiz R; Ferri MJ; de Bolós C; Figueras J; de Llorens R; Vidal-Vanaclocha F; Peracaula R
Int J Biochem Cell Biol; 2013 Aug; 45(8):1748-57. PubMed ID: 23726834
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-1beta induces sialyl Lewis X on hepatocellular carcinoma HuH-7 cells via enhanced expression of ST3Gal IV and FUT VI gene.
Higai K; Miyazaki N; Azuma Y; Matsumoto K
FEBS Lett; 2006 Nov; 580(26):6069-75. PubMed ID: 17054948
[TBL] [Abstract][Full Text] [Related]
4. Expression patterns of alpha 2,3-sialyltransferases and alpha 1,3-fucosyltransferases determine the mode of sialyl Lewis X inhibition by disaccharide decoys.
Brown JR; Fuster MM; Whisenant T; Esko JD
J Biol Chem; 2003 Jun; 278(26):23352-9. PubMed ID: 12686549
[TBL] [Abstract][Full Text] [Related]
5. Role of sialyltransferases involved in the biosynthesis of Lewis antigens in human pancreatic tumour cells.
Peracaula R; Tabarés G; López-Ferrer A; Brossmer R; de Bolós C; de Llorens R
Glycoconj J; 2005 Mar; 22(3):135-44. PubMed ID: 16133834
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: role in synthesis of E-selectin counter-receptors.
Majuri ML; Niemelä R; Tiisala S; Renkonen O; Renkonen R
Int J Cancer; 1995 Nov; 63(4):551-9. PubMed ID: 7591266
[TBL] [Abstract][Full Text] [Related]
7. Fucosyltransferase activities in human pancreatic tissue: comparative study between cancer tissues and established tumoral cell lines.
Mas E; Pasqualini E; Caillol N; El Battari A; Crotte C; Lombardo D; Sadoulet MO
Glycobiology; 1998 Jun; 8(6):605-13. PubMed ID: 9592127
[TBL] [Abstract][Full Text] [Related]
8. Effect of ST3GAL 4 and FUT 7 on sialyl Lewis X synthesis and multidrug resistance in human acute myeloid leukemia.
Ma H; Zhou H; Li P; Song X; Miao X; Li Y; Jia L
Biochim Biophys Acta; 2014 Sep; 1842(9):1681-92. PubMed ID: 24953795
[TBL] [Abstract][Full Text] [Related]
9. Carcinoembryonic antigen carrying SLe
Gomes C; Almeida A; Barreira A; Calheiros J; Pinto F; Abrantes R; Costa A; Polonia A; Campos D; Osório H; Sousa H; Pinto-de-Sousa J; Kolarich D; Reis CA
Theranostics; 2019; 9(24):7431-7446. PubMed ID: 31695778
[TBL] [Abstract][Full Text] [Related]
10. Expression of ST3GAL4 leads to SLe(x) expression and induces c-Met activation and an invasive phenotype in gastric carcinoma cells.
Gomes C; Osório H; Pinto MT; Campos D; Oliveira MJ; Reis CA
PLoS One; 2013; 8(6):e66737. PubMed ID: 23799130
[TBL] [Abstract][Full Text] [Related]
11. Regulation of glycosyltransferases and Lewis antigens expression by IL-1β and IL-6 in human gastric cancer cells.
Padró M; Mejías-Luque R; Cobler L; Garrido M; Pérez-Garay M; Puig S; Peracaula R; de Bolós C
Glycoconj J; 2011 Feb; 28(2):99-110. PubMed ID: 21365246
[TBL] [Abstract][Full Text] [Related]
12. 5-Aza-2'-deoxycytidine increases sialyl Lewis X on MUC1 by stimulating β-galactoside:α2,3-sialyltransferase 6 gene.
Chachadi VB; Cheng H; Klinkebiel D; Christman JK; Cheng PW
Int J Biochem Cell Biol; 2011 Apr; 43(4):586-93. PubMed ID: 21168523
[TBL] [Abstract][Full Text] [Related]
13. alpha(1,2)-fucosylation prevents sialyl Lewis x expression and E-selectin-mediated adhesion of fucosyltransferase VII-transfected cells.
Zerfaoui M; Fukuda M; Sbarra V; Lombardo D; El-Battari A
Eur J Biochem; 2000 Jan; 267(1):53-61. PubMed ID: 10601850
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa pyocyanin modulates mucin glycosylation with sialyl-Lewis(x) to increase binding to airway epithelial cells.
Jeffries JL; Jia J; Choi W; Choe S; Miao J; Xu Y; Powell R; Lin J; Kuang Z; Gaskins HR; Lau GW
Mucosal Immunol; 2016 Jul; 9(4):1039-1050. PubMed ID: 26555707
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus X protein specially regulates the sialyl lewis a synthesis among glycosylation events for metastasis.
Chung TW; Kim SJ; Choi HJ; Song KH; Jin UH; Yu DY; Seong JK; Kim JG; Kim KJ; Ko JH; Ha KT; Lee YC; Kim CH
Mol Cancer; 2014 Sep; 13():222. PubMed ID: 25255877
[TBL] [Abstract][Full Text] [Related]
16. Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.
Julien S; Ivetic A; Grigoriadis A; QiZe D; Burford B; Sproviero D; Picco G; Gillett C; Papp SL; Schaffer L; Tutt A; Taylor-Papadimitriou J; Pinder SE; Burchell JM
Cancer Res; 2011 Dec; 71(24):7683-93. PubMed ID: 22025563
[TBL] [Abstract][Full Text] [Related]
17. Specificity analysis of three clonal and five non-clonal alpha 1,3-L-fucosyltransferases with sulfated, sialylated, or fucosylated synthetic carbohydrates as acceptors in relation to the assembly of 3'-sialyl-6'-sulfo Lewis x (the L-selectin ligand) and related complex structures.
Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; DiCioccio RA; Matta KL
Biochemistry; 1996 Jul; 35(27):8925-33. PubMed ID: 8688428
[TBL] [Abstract][Full Text] [Related]
18. alpha-2,3-Sialyltransferase type 3N and alpha-1,3-fucosyltransferase type VII are related to sialyl Lewis(x) synthesis and patient survival from lung carcinoma.
Ogawa JI; Inoue H; Koide S
Cancer; 1997 May; 79(9):1678-85. PubMed ID: 9128982
[TBL] [Abstract][Full Text] [Related]
19. Selectin ligands and tumor-associated carbohydrate structures: specificities of alpha 2,3-sialyltransferases in the assembly of 3'-sialyl-6-sialyl/sulfo Lewis a and x, 3'-sialyl-6'-sulfo Lewis x, and 3'-sialyl-6-sialyl/sulfo blood group T-hapten.
Chandrasekaran EV; Jain RK; Larsen RD; Wlasichuk K; Matta KL
Biochemistry; 1995 Mar; 34(9):2925-36. PubMed ID: 7534477
[TBL] [Abstract][Full Text] [Related]
20. Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology.
Thomas LJ; Panneerselvam K; Beattie DT; Picard MD; Xu B; Rittershaus CW; Marsh HC; Hammond RA; Qian J; Stevenson T; Zopf D; Bayer RJ
Glycobiology; 2004 Oct; 14(10):883-93. PubMed ID: 15190008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
